PlainRecalls
FDA Drug Moderate Class II Terminated

Clopidogrel Tablets, USP, 75 mg, 500-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceutical Ltd., Baddi, Himachal, Pradesh, INDIA NDC 33342-060-15

Reported: September 8, 2021 Initiated: August 2, 2021 #D-0787-2021

Product Description

Clopidogrel Tablets, USP, 75 mg, 500-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceutical Ltd., Baddi, Himachal, Pradesh, INDIA NDC 33342-060-15

Reason for Recall

Presence of foreign matter

Details

Recalling Firm
Macleods Pharma Usa Inc
Units Affected
444,000 tablets / 888 unit packs of 500 count
Distribution
Product was distributed nationwide.
Location
Plainsboro, NJ

Frequently Asked Questions

What product was recalled?
Clopidogrel Tablets, USP, 75 mg, 500-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceutical Ltd., Baddi, Himachal, Pradesh, INDIA NDC 33342-060-15. Recalled by Macleods Pharma Usa Inc. Units affected: 444,000 tablets / 888 unit packs of 500 count.
Why was this product recalled?
Presence of foreign matter
Which agency issued this recall?
This recall was issued by the FDA Drug on September 8, 2021. Severity: Moderate. Recall number: D-0787-2021.